卖什么
Take Care of Shitty Paperwork for Expensive Drugs
商业模式拆解
买家：谁掌握预算？
未核实Pharmacy owners/operations leaders at specialty and infusion pharmacies (inferred).
触发点：什么让他们现在购买？
Staff turnover, 30% average prior-auth denial rate and 30+ minutes per specialty-drug prior authorization.
工作流：什么输入变成什么输出？
Unify intake from fax, EHR, portals and email; verify coverage and patient cost; validate medical necessity; automate prior authorization submission.
经济账：省了什么，怎么收费？
Claims 97% less staff time, 95% fewer errors, 50% faster time to fill; ROI vs manual labour and delays.
渠道：怎么接触到客户？
Demo-led (book a demo, ROI calculator on request), case studies, pharmacy operators podcast.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2021 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.